Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors

NCT02611544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2019-06-26

No results posted yet for this study

Summary

Fear of cancer recurrence (FCR) is one of the most prevalent, persistent, and disruptive sources of distress for adult cancer survivors. Prevalence rates for FCR have been estimated at up to 89%, with approximately half of cancer survivors reporting clinically significant levels of FCR. Despite the recognized prevalence, persistence, and suffering associated with FCR, effective and accessible treatments for FCR are lacking and urgently needed. Our long-term goal is to develop, evaluate, and implement effective behavioral interventions for cancer survivors suffering with FCR.

Conditions

  • Breast Neoplasms
  • Breast Cancer
  • Breast Carcinoma
  • Malignant Neoplasm of Breast
  • Cancer of Breast
  • Mammary Neoplasm, Human
  • Human Mammary Carcinoma
  • Malignant Tumor of Breast
  • Mammary Cancer
  • Mammary Carcinoma
  • Anxiety
  • Fear
  • Neoplasm Remission, Spontaneous
  • Spontaneous Neoplasm Regression
  • Regression, Spontaneous Neoplasm
  • Remission, Spontaneous Neoplasm
  • Spontaneous Neoplasm Remission

Interventions

BEHAVIORAL

Acceptance and Commitment Therapy

6-week ACT intervention group (n=33)

BEHAVIORAL

Survivorship Education

6-week survivorship education group (SE; n=32)

BEHAVIORAL

Enhanced Usual Care

enhanced usual care (EUC; n=26)

Sponsors & Collaborators

  • Indiana University Health

    collaborator OTHER
  • Indiana University

    lead OTHER

Principal Investigators

  • Shelley A Johns, PsyD · Indiana University School of Medicine; Regenstrief Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-01
Completion
2016-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02611544 on ClinicalTrials.gov